Pathogenetic role of the tyrosine-phosphorylated CagA EPIYA sequence of Helicobacter pylori in histological gastritis in Japanese patients

Journal of Gastroenterology

Volumn 44, Issue 5, 2009, Pages 405-411

  Takata, Shunsuke ^a   Ito, Masanori ^a   Wada, Yoshihiro ^a   Yoshihara, Masaharu ^b   Tanaka, Shinji ^c   Chayama, Kazuaki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

CagA; ELISA; Gastritis; Helicobacter pylori; Immunohistochemistry

Indexed keywords

ALANINE; CAGA P ANTIBODY; CAGA PROTEIN; GLUTAMIC ACID; ISOLEUCINE; PROLINE; PROTEIN ANTIBODY; TYROSINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRITIS; GENE SEQUENCE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; JAPANESE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; STOMACH BIOPSY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID MOTIFS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHOSPHORYLATION; TYROSINE; YOUNG ADULT;

EID: 67349205425     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0015-0     Document Type: Article

References (30)

1. Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: Present status and future prospects in Japan. J Gastroenterol. 2007;42:1-15.
2. Suzuki H, Hibi T. Oxidative stress in Helicobacter pylori -associated gastroduodenal disease. J Clin Biochem Nutr. 2006;39:56-63.
3. Matsumoto Y, Ito M, Kamino D, Tanaka S, Haruma K, Chayama K. Relation between histologic gastritis and gastric motility in Japanese patients with functional dyspepsia: Evaluation by transabdominal ultrasonography. J Gastroenterol. 2008;43:332-7.
4. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 2003;125:1636-44.
5. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer. 2004;4:688-94.
6. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature. 2007;447:330-3.
7. Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA. 2002;99:14428-33.
8. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295:683-6.
9. Maeda S, Yoshida H, Ikenoue T, Ogura K, Kanai F, Kato N, et al. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut. 1999;44:336-41.
10. Ueda H, Ito M, Eguchi H, Tanaka S, Yoshihara M, Haruma K, et al. Development of a novel method to detect Helicobacter pylori cagA genotype from paraffin-embedded materials: Comparison between patients with duodenal ulcer and gastric cancer in young Japanese. Digestion. 2006;73:47-53.
11. Chiba T, Seno H, Marusawa H, Wakatsuki Y, Okazaki K. Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol. 2006;41:1-9.
12. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The Updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Path. 1996;20:1161-81.
13. Yoshihara M, Sumii K, Haruma K, Kiyohira K, Hattori N, Kitadai Y, et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects. Am J Gastroenterol. 1998;93:1090-6.
14. Ito M, Haruma K, Kaya S, Kamada T, Kim S, Sasaki A, et al. Role of anti-parietal cell antibody in Helicobacter pylori-associated atrophic gastritis: Evaluation in a country of high prevalence of atrophic gastritis. Scand J Gastroenterol. 2002;37:287-93.
15. Kai H, Ito M, Kitadai Y, Tanaka S, Haruma K, Chayama K. Chronic gastritis with expression of inducible nitric oxide synthase is associated with high expression of interleukin-6 and hypergastrinaemia. Aliment Pharmacol Ther. 2004;19:1309-14.
16. Goto T, Haruma K, Kitadai Y, Ito M, Yoshihara M, Sumii K, et al. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin Cancer Res. 1999;5:1411-5.
17. Ito M, Yasui W, Kyo E, Yokozaki H, Nakayama H, Ito H, et al. Growth inhibition of transforming growth factor beta on human gastric carcinoma cells: Receptor and postreceptor signaling. Cancer Res. 1992;52:295-300.
18. Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer. 2006;9:245-53.
19. Handa O, Naito Y, Yoshikawa T. CagA protein of Helicobacter pylori: A hijacker of gastric epithelial cell signaling. Biochem Pharmacol. 2007;73:1697-702.
20. Ren S, Higashi H, Lu H, Azuma T, Hatakeyama M. Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J Biol Chem. 2006;281:32344-52.
21. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA. 2008;105:1003-8.
22. Xie XF, Ito M, Sumii M, Tanaka S, Yoshihara M, Chayama K. Helicobacter pylori-associated gastritis is related to babA2 expression without heterogeneity of the 3′ region of the cagA genotype in gastric biopsy specimens. Pathobiology. 2007;74:309-16.
23. Azuma T, Kato S, Zhou W, Yamazaki S, Yamakawa A, Ohtani M. Diversity of vacA and cagA genes of Helicobacter pylori in Japanese children. Aliment Pharmacol Ther. 2004;20(Suppl 1):7-12.
24. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-9.
25. Imagawa S, Yoshihara M, Ito M, Yoshida S, Wada Y, Tatsugami M, et al. Evaluation of gastric cancer risk using topography of histological gastritis: A large-scaled cross-sectional study. Dig Dis Sci. 2008;53:1818-23.
26. Matsumoto Y, Marusawa H, Kinoshita K, Endo Y, Kou T, Morisawa T, et al. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med. 2007;13:470-6.
27. Naito Y, Ito M, Watanabe T, Suzuki H. Biomarkers in patients with gastric inflammation: A systematic review. Digestion. 2005;72:164-80.
28. Shibata W, Hirata Y, Maeda S, Ogura K, Ohmae T, Yanai A, et al. CagA protein secreted by the intact type IV secretion system leads to gastric epithelial inflammation in the Mongolian gerbil model. J Pathol. 2006;210:306-14.
29. Argent RH, Hale JL, El-Omar EM, Atherton JC. Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. J Med Microbiol. 2008;57:1062-7.
30. Javier R, Raska K Jr, Shenk T. Requirement for the adenovirus type 9 E4 region in production of mammary tumors. Science. 1992;257:1267-71.